GreenLight Biosciences Holdings PBC
(NASDAQ : GRNA)

( )
GRNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.79%245.431.5%$930.12m
MRNAModerna, Inc. 0.44%142.810.0%$790.53m
REGNRegeneron Pharmaceuticals, Inc. 0.54%597.622.6%$505.40m
VRTXVertex Pharmaceuticals, Inc. 1.51%280.351.9%$504.03m
GILDGilead Sciences, Inc. 0.43%62.481.0%$502.90m
NVAXNovavax, Inc. 1.55%51.8575.7%$413.51m
ILMNIllumina, Inc. -0.53%186.433.3%$349.53m
SNSSSunesis Pharmaceuticals, Inc. 6.29%3.550.7%$248.16m
BIIBBiogen, Inc. 1.34%205.231.8%$246.04m
BNTXBioNTech SE 1.55%141.980.0%$168.44m
CRSPCRISPR Therapeutics AG -0.44%63.000.6%$166.23m
BMRNBioMarin Pharmaceutical, Inc. 0.93%83.924.2%$122.49m
EXASEXACT Sciences Corp. -1.29%40.5817.7%$95.83m
TECHBio-Techne Corp. 0.72%348.504.5%$93.10m
IOVAIovance Biotherapeutics, Inc. -0.82%10.890.0%$92.14m

Company Profile

GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. Its breakthrough biomanufacturing platform is engaged in discovering, developing, scaling, and commercializing RNA solutions at volume across multiple sectors in the agricultural and human health markets. The company is headquartered in Medford, MA.